DE69033970D1 - Huperzin a analoge verbindungen - Google Patents

Huperzin a analoge verbindungen

Info

Publication number
DE69033970D1
DE69033970D1 DE69033970T DE69033970T DE69033970D1 DE 69033970 D1 DE69033970 D1 DE 69033970D1 DE 69033970 T DE69033970 T DE 69033970T DE 69033970 T DE69033970 T DE 69033970T DE 69033970 D1 DE69033970 D1 DE 69033970D1
Authority
DE
Germany
Prior art keywords
huperzin
analogue connections
analogue
connections
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69033970T
Other languages
English (en)
Other versions
DE69033970T2 (de
Inventor
P Kozikowski
Yan Xia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Original Assignee
Mayo Foundation for Medical Education and Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research filed Critical Mayo Foundation for Medical Education and Research
Publication of DE69033970D1 publication Critical patent/DE69033970D1/de
Application granted granted Critical
Publication of DE69033970T2 publication Critical patent/DE69033970T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DE69033970T 1989-02-21 1990-02-21 Huperzin a analoge verbindungen Expired - Fee Related DE69033970T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/313,118 US4929731A (en) 1989-02-21 1989-02-21 Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
PCT/US1990/000925 WO1990009993A2 (en) 1989-02-21 1990-02-21 Method for the synthesis of huperzine a and analogs thereof and compounds useful therein

Publications (2)

Publication Number Publication Date
DE69033970D1 true DE69033970D1 (de) 2002-07-18
DE69033970T2 DE69033970T2 (de) 2002-10-02

Family

ID=23214460

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69033970T Expired - Fee Related DE69033970T2 (de) 1989-02-21 1990-02-21 Huperzin a analoge verbindungen
DE69034070T Expired - Fee Related DE69034070T2 (de) 1989-02-21 1990-02-21 Racemisches Huperzin A
DE69034226T Expired - Fee Related DE69034226T2 (de) 1989-02-21 1990-02-21 Verfahren zur Synthese von Huperzin A und Analoge desselben sowie von darin verwendbaren Verbindungen

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69034070T Expired - Fee Related DE69034070T2 (de) 1989-02-21 1990-02-21 Racemisches Huperzin A
DE69034226T Expired - Fee Related DE69034226T2 (de) 1989-02-21 1990-02-21 Verfahren zur Synthese von Huperzin A und Analoge desselben sowie von darin verwendbaren Verbindungen

Country Status (9)

Country Link
US (1) US4929731A (de)
EP (3) EP1167354B1 (de)
JP (1) JP2933386B2 (de)
AT (3) ATE330943T1 (de)
CA (2) CA2296915A1 (de)
DE (3) DE69033970T2 (de)
DK (2) DK1167354T3 (de)
ES (2) ES2194003T3 (de)
WO (1) WO1990009993A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177082A (en) * 1985-11-05 1993-01-05 Yu Chao Mei Huperzines and analogs
US5104880A (en) * 1991-05-01 1992-04-14 Mayo Foundation For Medical Education And Research Huperzine a analogs as acetylcholinesterase inhibitors
US5145973A (en) * 1991-09-30 1992-09-08 Union Carbide Chemicals & Plastics Technology Corporation Oxa-Bicyclic polyfunctional compounds and preparation thereof
US5206393A (en) * 1991-09-30 1993-04-27 Union Carbide Chemicals & Plastics Technology Corporation Oxa-bicyclic polyfunctional compounds and preparation thereof
US5547960A (en) * 1994-09-07 1996-08-20 Mayo Foundation For Medical Education And Research C-10 analogs of huperzine a
USRE38460E1 (en) 1994-12-28 2004-03-09 Shanghai Institute Of Materia Medica Chinese Academy Of Sciences Huperzine A derivatives, their preparation and their use
CN1125725A (zh) * 1994-12-28 1996-07-03 中国科学院上海药物研究所 一类海克林碱衍生物及它的用途
WO2001000215A1 (en) * 1999-06-25 2001-01-04 Wake Forest University Compositions for treating or preventing neurodegeneration and cognitive decline
US6271379B1 (en) 2000-03-08 2001-08-07 Georgetown University Intermediates useful for the synthesis of huperzine A
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
US6369052B1 (en) 2000-08-07 2002-04-09 Georgetown University Combination of huperzine and nicotinic compounds as a neuroprotective agent
KR100390777B1 (ko) * 2000-12-19 2003-07-10 한국화학연구원 피리돈 유도체의 제조방법
US6967206B2 (en) 2002-12-05 2005-11-22 Access Business Group International Llc Compositions and methods for increasing growth hormone levels
EP3056200B1 (de) 2005-05-23 2023-09-06 President and Fellows of Harvard College Huperzin zur verwendung in der behandlung von einem anfall
US8097726B2 (en) * 2006-05-17 2012-01-17 Industrial Technology Research Institute Huperzine a compound for treatment of alzheimer's disease
WO2009120774A2 (en) * 2008-03-25 2009-10-01 Debiopharm S.A. Method of preparing huperzine a and derivatives thereof
WO2010028134A2 (en) * 2008-09-04 2010-03-11 President And Fellows Of Harvard College Treatment of neurological disorders using huperzine
CN104496998B (zh) * 2014-12-15 2017-07-11 陕西嘉禾生物科技股份有限公司 一种1′‑苄基‑2′‑酮‑5′，7′，8′‑三氢‑螺‑[1，3‑二氧五环‑2]‑喹啉的制备方法
CN104496900A (zh) * 2014-12-15 2015-04-08 陕西嘉禾植物化工有限责任公司 一种2-甲氧基-6-酮-5,7,8-三氢-喹啉的制备方法
CN109705038B (zh) * 2017-10-25 2020-11-03 广州市朗启医药科技有限责任公司 石杉碱甲的合成方法
CN114716449B (zh) * 2022-04-12 2023-09-29 浙江工业大学 一种2-甲氧基-6-乙二醇缩酮-5,7,8-三氢喹啉的制备方法
CN119431243B (zh) * 2025-01-09 2025-06-10 万邦德制药集团有限公司 一种氘代石杉碱甲化合物或其药学上可接受的盐及其制备方法和应用

Also Published As

Publication number Publication date
CA2296915A1 (en) 1990-08-22
HK1030604A1 (en) 2001-05-11
EP1026157A2 (de) 2000-08-09
EP1167354A3 (de) 2002-01-09
EP1026157A3 (de) 2004-08-11
DK0460062T3 (da) 2002-08-26
CA2047744C (en) 2000-05-02
DE69034070T2 (de) 2003-12-18
EP1026157B1 (de) 2006-06-21
ATE330943T1 (de) 2006-07-15
EP0460062A4 (en) 1992-07-01
US4929731A (en) 1990-05-29
ATE239709T1 (de) 2003-05-15
WO1990009993A3 (en) 1990-11-01
JP2933386B2 (ja) 1999-08-09
DE69034226D1 (de) 2006-08-03
CA2047744A1 (en) 1990-08-22
WO1990009993A2 (en) 1990-09-07
ATE219061T1 (de) 2002-06-15
EP1167354B1 (de) 2003-05-07
ES2173858T3 (es) 2002-11-01
DE69033970T2 (de) 2002-10-02
DE69034070D1 (de) 2003-06-12
EP1167354A2 (de) 2002-01-02
EP0460062A1 (de) 1991-12-11
ES2194003T3 (es) 2003-11-16
DK1167354T3 (da) 2003-09-01
EP0460062B1 (de) 2002-06-12
DE69034226T2 (de) 2007-06-21

Similar Documents

Publication Publication Date Title
DE69033970D1 (de) Huperzin a analoge verbindungen
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
DE50015623D1 (de) Kovalent verbrückte insulindimere
SE9504661D0 (sv) New compounds
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ATE427103T1 (de) Orale verabreichung von adenosin analogen
SE9201628D0 (sv) Pharmaceutical composition
DE58909850D1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
ATE252885T1 (de) Plan zur verabreichung von h+, k+-atpase inhibitoren
NO971568D0 (no) Analoger av keratinocyttvekstfaktor
SE8804570D0 (sv) New ciclosporin crystal form process for its produktion pharmaceutical compositions containing it and its use
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
MD2196B2 (ro) Criptoficine, procedeu de obţinere, compoziţii farmaceutice pe baza acestora, metodă de inhibare a proliferării celulelor mamiferelor şi metodă de atenuare a stării patologice cauzate de hiperproliferarea celulelor mamiferelor
PT98371A (pt) Processo para a preparacao de derivados 6-alcoxi de arabinofuranosil-guanina e de composicoes farmaceuticas que os contem
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
PT1007040E (pt) Utilizacao de fanquinona no tratamento da doenca de alzheimer
SE9504662D0 (sv) New compounds
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
YU2394A (sh) Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee